The page is the record's research on the issuer — no analyst, no rating, no view.

# ROCKWELL MEDICAL, INC. (NASDAQ: RMTI) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is ROCKWELL MEDICAL, INC., listed on NASDAQ under the ticker RMTI. Its LEI is 529900Y6YUB5X93MMD77; its ISIN is not on the record, and the LEI carries several US ISINs, US7743742014 and US7743744093. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.

## The disclosure read

The record holds 54 filings across 23 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 10.0 days, and the median gap for the exchange NASDAQ is 6.0 days across 4359 issuers. The median gap for the sector 2834 Pharmaceutical Preparations is 6.0 days across 526 issuers. The latest filing is dated 2026-11-03, is of type corporate_news, and falls 5 days before the record date. The median latency is 5.0 days for the exchange and 4.0 days for the sector. Filings by type are: ad_hoc 1, agm_egm 4, corporate_news 7, director_change 1, directors_dealings 25, halt_suspension 1, regulatory_filing 6, results 9.

## Auditor

The auditor of record is EISNERAMPER LLP, located in Iselin, New Jersey. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

The record finds two research houses named on the issuer's investor-relations page: H.C. Wainwright & Co. and Maxim Group LLC.

## Open research

The record holds no openly published research notes, as none was found.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The vintage is sealed. The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://data.sec.gov/submissions/CIK0001041024.json (identity.jurisdiction)
- https://api.gleif.org/api/v1/lei-records/529900Y6YUB5X93MMD77 (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/RMTI (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1041024/000162828026021186/rmti-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://ir.rockwellmed.com/stock-info/analyst-coverage/default.aspx (coverage)
- https://mcp.us-cm-kg.ai/record/NASDAQ/RMTI (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/RMTI · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp